The Estée Lauder Companies Completes Acquisition of DECIEM
The Estée Lauder Companies (NYSE: EL) has completed its acquisition of DECIEM Beauty Group, a Canadian-based multi-brand company, for an estimated $860 million, totaling around $1.7 billion from initial investment to final acquisition. DECIEM, known for its flagship brand The Ordinary, has shown significant growth and innovation. This acquisition aims to bolster ELC's skin care portfolio and global consumer reach, with DECIEM's brands ranking highly in multiple international markets. The partnership has leveraged ELC's infrastructure for global expansion and increased profitability through operational efficiencies.
- ELC completed the acquisition for $860 million, with a total investment of approximately $1.7 billion.
- DECIEM's flagship brand, The Ordinary, ranked top two in prestige skin care in Canada and the U.S., and top four in France, Germany, and the U.K. for Q1 2024.
- The Ordinary achieved significant global expansion with launches in India, the Middle East, and South Africa.
- ELC's infrastructure has driven DECIEM's increased profitability through operational efficiencies.
- DECIEM's innovative products like Multi-Peptide Lash and Brow Serum have driven sales and brand growth.
- The acquisition aligns with ELC's strategy to expand its skin care portfolio and consumer base.
- The total investment in DECIEM, net of cash, approximates $1.7 billion, a significant outlay.
- The acquisition cost of $860 million was paid using cash on hand, which could impact ELC's liquidity.
- Post-closing adjustments to the purchase price may lead to further financial adjustments.
Insights
The Estée Lauder Companies (ELC) completing its acquisition of DECIEM is a noteworthy development with significant implications for investors. From a financial standpoint, ELC's $1.7 billion investment over three tranches, culminating in an estimated $860 million final purchase, shows the company's commitment to expanding its portfolio through strategic acquisitions. This transaction is poised to enhance ELC's revenue streams, particularly from DECIEM's flagship brand, The Ordinary, which has a strong market presence.
By leveraging DECIEM's agility and vertically integrated structure, ELC can potentially improve its operational efficiencies and profitability. Moreover, ELC’s ability to fund this acquisition using cash on hand demonstrates strong liquidity, reducing the financial risk of additional debt. However, investors should be aware of post-closing adjustments that may impact the final financial figures.
In the short term, this acquisition is likely to positively influence ELC's stock price due to the anticipated synergies and expanded consumer reach. Long-term benefits include enhanced innovation capabilities and a stronger market position. Yet, there are risks associated with integrating DECIEM’s operations fully into ELC’s framework, which could pose challenges.
From a market research perspective, ELC's acquisition of DECIEM represents a strategic move to capitalize on evolving consumer preferences, particularly among millennials and Gen Z. DECIEM’s transparency and authenticity resonate with these demographics, making it a valuable asset for ELC.
DECIEM’s multi-brand strategy and its flagship brand, The Ordinary, have disrupted traditional beauty market norms by emphasizing ingredient transparency and science-backed products. This approach has allowed DECIEM to capture significant market share in key regions such as North America and Europe. Expanding into new markets like India, the Middle East and South Africa further diversifies ELC’s consumer base and reduces dependence on established markets.
The integration of DECIEM's innovative products, like the Multi-Peptide Lash and Brow Serum, into ELC's portfolio underscores the importance of continued product innovation in maintaining competitive advantage. However, there is an inherent risk in maintaining DECIEM's brand identity and consumer trust during and after the integration process, which investors should monitor closely.
In the realm of technology and product development, DECIEM’s acquisition by ELC signifies the importance of technology-driven innovation in the beauty industry. DECIEM’s in-house labs and its approach to tech-led skin science, particularly with brands like NIOD, highlight the increasing role of scientific research and development in creating effective skincare solutions.
Vertically integrated structures like DECIEM’s provide significant competitive advantages, enabling quicker response to market trends and consumer demands. This structure supports rapid innovation cycles, as evidenced by DECIEM’s successful product launches, which align with current scientific advancements and consumer needs.
ELC's ability to harness DECIEM's technological expertise and integrate it with their existing R&D infrastructure could further streamline product development processes and enhance the quality and efficacy of new offerings. For retail investors, this indicates potential for sustained long-term growth driven by innovation and technological advancements.
Known as “The Abnormal Beauty Company,” DECIEM’s dedication to ingredient transparency, agility, end-to-end capabilities, and passionate global community of skin care devotees help to expand ELC’s skin care portfolio to reach even more global consumers. The company’s innovative multi-brand strategy, propelled by an agile and vertically integrated structure, enables the rapid ability to create and capture opportunities and trends to delight consumers around the world. DECIEM’s flagship brand, The Ordinary, is a consumer-beloved industry disruptor that ranked top two in prestige skin care in its home markets of
“We are incredibly proud of what DECIEM is accomplishing,” said Fabrizio Freda, President and Chief Executive Officer, ELC. “In our seven years of partnership, DECIEM has achieved impressive growth while continuing its core mission of reimagining effective, high-quality skin care for today’s diverse and sophisticated consumers. As a digitally native organization with a highly engaged following among millennial and Gen Z consumers, DECIEM helps to strategically expand our skin care portfolio, and we believe there are many more exciting growth opportunities ahead.”
"Today The Estée Lauder Companies becomes the forever home of DECIEM,” said Nicola Kilner, Co-Founder and CEO DECIEM. “Our founder Brandon set out to disrupt the world of beauty, and this thinking has been embraced by ELC over the past seven years of our partnership. Their support, along with the energy of our incredibly talented team, has allowed us to strengthen our operational capabilities and enter new markets, while staying true to our founding values of transparency, quality, and authenticity."
ELC’s progressive investment strategy has allowed it to build a long-term partnership with DECIEM rooted in a shared legacy of innovation and entrepreneurship. Since 2017, DECIEM has leveraged ELC’s infrastructure and resources to expand consumer reach globally and drive stronger profitability through operational efficiencies.
Tapping into consumer desire for effective, science-backed skin care, The Ordinary is in ELC’s tier of scaling brands, each with net sales between
Founded in 2013 by the late Brandon Truaxe, a visionary who championed authenticity and transparency in the beauty industry, DECIEM joined ELC with brand incubation capabilities and a portfolio that, in addition to The Ordinary, also includes NIOD, a pioneer in tech-led skin science, and AVESTAN, a fragrance brand that honors Brandon’s vision. DECIEM is headquartered in
“DECIEM is an exceptional company with authentic brands, highly effective must-have products, and a uniquely transparent and engaging relationship with its devoted consumers around the world,” said Stéphane de La Faverie, Executive Group President, ELC. “We have enjoyed a fantastic partnership over the last seven years, and we are thrilled to continue our journey together.”
“DECIEM and its brands embody the values of fearless persistence, uncompromising quality, and deep integrity that shape how we do business at The Estée Lauder Companies,” said William P. Lauder, Executive Chairman, ELC. “We are grateful to the entire DECIEM team for its leadership and hard work, and we are tremendously excited to see what we can continue to achieve together in the months and years ahead.”
The forward-looking statements in this press release, including those in the quoted remarks expectations for DECIEM and the ongoing benefits of the acquisition, involve risks and uncertainties. Factors that could cause actual results to differ materially from those forward-looking statements include current economic, geopolitical and other conditions in the global marketplace, actions by retailers, suppliers and consumers, competition, the ongoing integration of the DECIEM business and/or the ability to implement DECIEM’s long-term strategic plan, and those risk factors described in ELC’s annual report on Form 10-K for the year ended June 30, 2023.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN
ELC-C
ELC-F
ELC-B
View source version on businesswire.com: https://www.businesswire.com/news/home/20240603987285/en/
Media Relations:
Jill Marvin
jimarvin@estee.com
Investor Relations:
Rainey Mancini
rmancini@estee.com
Source: The Estée Lauder Companies Inc.
FAQ
When did Estée Lauder complete the acquisition of DECIEM?
What is the total investment Estée Lauder made in acquiring DECIEM?
Which brand is DECIEM most known for?
How did DECIEM rank in the prestige skin care market?
What impact did ELC's infrastructure have on DECIEM?
Which new markets did The Ordinary enter recently?
What innovative products has DECIEM launched recently?
